BLI shows that the RaST group significantly suppressed tumor progression (p=0.0038) compared to the insignificant outcomes with TiO2-TC-Tf (p= 0.2215) and 18FDG (p= 0.3912) relative to the untreated control (Fig. 2o), which correlated with data from caliper measurements (Supplementary Fig. 5A-F). The gene discussed is TF; the disease is neoplasm.